1 – 6 of 6
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2007
- 
                        Mark
        Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients
    
    - Contribution to journal › Article
 
- 2005
- 
                        Mark
        Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
    
    - Contribution to journal › Article
 
- 
                        Mark
        Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
    
    - Contribution to journal › Article
 
- 2004
- 
                        Mark
        Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Hereditary thrombophilia and fetal loss: a prospective follow-up study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Familial thrombophilia and lifetime risk of venous thrombosis
    
    - Contribution to journal › Article